YI

Financial Performance: 111, Inc. reported stable net revenues of RMB 3.5 billion for Q1 2025, with a slight year-over-year decrease in income from operations and a net loss of RMB 7.3 million, while maintaining positive operating cash flow and reducing operating expenses as a percentage of revenues.

Operational Efficiency: The company achieved a 4.8% reduction in total operating expenses compared to the previous year, highlighting improvements in operational efficiency driven by cost management strategies, particularly in selling, marketing, and technology expenses.

Financial Performance: 111, Inc. reported a wider net loss of RMB17.65 million in Q1 due to increased expenses, with nearly flat net revenues of RMB3.529 billion, reflecting only a 0.02% increase from the previous year.

Future Strategy: CEO Junling Liu emphasized the company's focus on leveraging technology and investing in AI and digital solutions to enhance their healthcare supply chain and customer engagement.

Financial Performance: 111, Inc. reported its first-ever annual operating profit of RMB2.1 million in 2024, alongside a positive operating cash flow of RMB263 million, despite facing a challenging macroeconomic environment that led to a decrease in net revenues and gross segment profit year-over-year.

Operational Efficiency: The company improved its operational efficiency significantly, with total operating expenses as a percentage of revenues decreasing by 230 basis points to 5.7% for the fiscal year, while also achieving notable reductions in various expense categories, including selling and marketing costs.